Search
for
Sort by
Research 241–270 of 1000+
- ALOPECIA AREATA: PADRÕES DE QUEDA DE CABELO, MODALIDADES DE TRATAMENTO E IMPACTO PSICOLÓGICO
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Dermatologic Adverse Events from Cancer Treatments
- Androgen Receptor Ligands: Agonists and Antagonists
- Update on Frontal Fibrosing Alopecia
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Current and future pharmacotherapy for alopecia areata
- Skin
- Dermatologic Care of the Transplant Patient
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Pharmacological Treatment of Alopecia
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Investigating drug induced alopecia
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Hyperinnervation inhibits organ-level regeneration in mammalian skin
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Pharmacotherapy of alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology